Efficacy and Safety of Oral Dofetilide in Converting to and Maintaining Sinus Rhythm in Patients With Chronic Atrial Fibrillation or Atrial Flutter: The Symptomatic Atrial Fibrillation Investigative Research on Dofetilide (SAFIRE-D) Study

Singh, Steven, Zoble, Robert G., Yellen, Laurence, Brodsky, Michael A., Feld, Gregory K., Berk, Martin, Billing, Clare B.·2000·Circulation
DOI 10.1161/01.cir.102.19.2385

Cited by (432)

Items 301–400 of 432

  1. Atrial Flutter — Diagnosis, Management and Treatment
    Shameer Ahmed, Andrew Claughton, Paul A. Gould · 2015 · InTech eBooks
  2. ADVANCES IN CARDIAC ELECTROPHYSIOLOGY AND PACING
    Fei Lü, Richard G. Trohman · 2001 · Critical Care Clinics
  3. Cardioversion of atrial tachyarrhythmias: anticoagulation to reduce thromboembolic complications
    Hongsheng Guo, Wassim H. Shaheen, Richard E. Kerber, Brian Olshansky · 2004 · Progress in Cardiovascular Diseases
  4. Diagnostic Evaluation and Follow-Up of Patients with Atrial Fibrillation
    Patrick Dillon, Hamid Ghanbari · 2014 · Cardiology Clinics
  5. Drug treatment of supraventricular tachycardia: Table 1
    Carina Blomström‐Lundqvist · 2009 · Heart
  6. Antiarrhythmic Drugs
    Dobromir Dobrev, Bramah N. Singh · 2012 · Elsevier eBooks
  7. The management of atrial fibrillation in heart failure
    Rupa Bala, David J. Callans · 2006 · Current Treatment Options in Cardiovascular Medicine
  8. Some Recent Randomized Clinical Trials in the Management of Atrial Fibrillation
    D. George Wyse · 2003 · Journal of Interventional Cardiac Electrophysiology
  9. Long‐Term Pharmacologic Management of Atrial Fibrillation in the Elderly
    Albert L. Waldo · 2002 · The American Journal of Geriatric Cardiology
  10. Characterization of hERG K+ channel inhibition by the new class III antiarrhythmic drug cavutilide
    Абрамочкин Денис Валерьевич, Ksenia B. Pustovit, Nikolay Yu. Mironov, Tatiana S. Filatova, Tatiana Nesterova · 2024 · Naunyn-Schmiedeberg s Archives of Pharmacology
  11. Spectral Analysis of Baseline Electrocardiogram During Atrial Fibrillation Predicts Response to Antiarrhythmic Drug Therapy in Patients With Persistent Atrial Fibrillation
    Stavros Stavrakis, JOHN W. DYER, Edward Koomson, Benjamin J. Scherlag, Bhaskar Bhardwaj, Ralph Lazzara, Sunny S. Po · 2016 · Journal of Cardiovascular Electrophysiology
  12. Similarities and differences between atrial flutter and atrial fibrillation.
    Christopher S. Simpson, L. Brent Mitchell, George Joseph Klein · 2005 · PubMed
  13. A practical approach to the management of patients with atrial fibrillation
    Christopher John McLeod, Bernard John Gersh · 2010 · Heart Asia
  14. Role of Dofetilide in Patients with Atrial Fibrillation. Insights from the Symptomatic Atrial Fibrillation Investigative Research on Dofetilide (SAFIRE-D) Study
    Steven N Singh · 2003 · Cardiac Electrophysiology Review
  15. Prevention of Torsade de Pointes during the Pharmacologic Treatment of Atrial Fibrillation
    Hideo Mitamura · 2010 · Journal of Arrhythmia
  16. Update of the Clinical Impact and Issues Surrounding Dofetilide (Tikosyn) Therapy
    Lyudmila Friedman, Earnest Alexander · 2006 · AACN Advanced Critical Care
  17. Recent Advances in the Pharmacological Management of Atrial Fibrillation
    Janelle Yoland Gooden, Brian D. Powell, Clement O. Akogyeram, Rowlens M. Melduni · 2013 · American Journal of Therapeutics
  18. Acute anticoagulation adjustment in patients with atrial fibrillation at risk for stroke: approaches, strategies, risks and benefits
    Brian Olshansky, Hongsheng Guo · 2005 · Expert Review of Cardiovascular Therapy
  19. Diagnostic Evaluation and Follow-Up of Patients with Atrial Fibrillation
    Patrick Dillon, Hamid Ghanbari · 2016 · Heart Failure Clinics
  20. Strategies for the Management of Postoperative Atrial Fibrillation
    Jennifer G Bekker, Tracy E. Macaulay · 2011 · Orthopedics
  21. ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmiasM — executive summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Supraventricular Arrhythmias)
    Joseph S. Alpert, Elliott Marshall Antman, Sidney C. Smith, David P. Faxon, Valentı́n Fuster, Raymond J. Gibbons, Gabriel Gregoratos, Loren F. Hiratzka, Sharon A. Hunt, Alice K. Jacobs et al. · 2003
  22. Atrial Fibrillation in Patients with Cardiac Resynchronization Therapy: Therapeutic Options
    Dubravko Petrač · 2017 · Cardiologia Croatica
  23. Evaluation of the Impact of an Institution-Specific Dofetilide Initiation Protocol on Mean Hospital Length of Stay and Cost for Dofetilide Initiation
    Steven P. Kennedy, Hanna R. Iaizzo, Evgueni Fayn, Dalip Singh · 2018 · PharmacoEconomics - Open
  24. Stroke or side effect? dofetilide associated facial paralysis after direct current cardioversion for atrial fibrillation
    Lane Zhang, David A. Steckman · 2019 · BMJ Case Reports
  25. Pharmacist-Managed Inpatient Dofetilide Initiation Program: Description and Adherence Rate Post-Root Cause Analysis
    Elena Ko, Charles M. Carpenter, David J. Gagnon, Anne M. Andrle · 2019 · Journal of Pharmacy Practice
  26. Safety of Inpatient Dofetilide Initiation per Cardiology Services: A Retrospective Review
    Carrie Cicirale, Jennifer Jackson, David Gothard · 2021 · Journal of Pharmacy Practice
  27. Mechanisms of Action of Antiarrhythmic Drugs
    Wei Li, Yi‐Gang Li, Gan‐Xin Yan · 2020 · Contemporary cardiology
  28. Anti-arrhythmic Drugs—a Review and Comment on Relevance in the Current Era: Part 1
    Seri Hanayneh, Mark Edward Panna, William M. Miles, Ramil Goel · 2021 · Current Treatment Options in Cardiovascular Medicine
  29. Assessment of Dofetilide or Sotalol Tolerability in the Elderly
    Nikitha Yagnala, Lindsay Moreland-Head, Joseph J Zieminski, Kristin C. Mara, Shea A. Macielak · 2024 · Journal of Cardiovascular Pharmacology and Therapeutics
  30. Dofetilide: A New Class III Antiarrhythmic for the Management of Atrial Fibrillation
    Antonette L. Diaz, G. Dennis Clifton · 2001 · Progress in Cardiovascular Nursing
  31. Pharmacologic Conversion of Atrial Fibrillation and Atrial Flutter
    Alessandro Marinelli, Alessandro Capucci · 2010 · Cardiac Electrophysiology Clinics
  32. Dronedarone treatment following cardioversion in patients with atrial fibrillation/flutter: A post hoc analysis of the EURIDIS and ADONIS trials
    Munveer Thind, Harry J.G.M. Crijns, Gerald V. Naccarelli, James A. Reiffel, Mattias Wieloch, Andrew Koren, Peter Russell Kowey · 2020 · Journal of Cardiovascular Electrophysiology
  33. New Antiarrhythmic Pharmacologic Therapies and Regulatory Issues in Antiarrhythmic Drug Development
    Heather Ross, Peter Russell Kowey, Gerald V. Naccarelli · 2005
  34. Maintaining stability of sinus rhythm in atrial fibrillation: Antiarrhythmic drugs versus ablation
    Gerald V. Naccarelli, John K. Hynes, Deborah L. Wolbrette, Luna Bhatta, M. Rashid Khan, Jerry C. Luck · 2002 · Current Cardiology Reports
  35. New antiarrhythmic agents for atrial fibrillation
    Anirban Choudhury, Gregory Y.H. Lip · 2004 · Therapy
  36. Pharmakologische Therapie von Vorhofflimmern und Vorhofflattern
    Gerian Grönefeld, Yi‐Gang Li, Stefan Hans Hohnloser · 2002 · Herz
  37. Atrial Fibrillation: Antiarrhythmic Therapy
    Harry J.G.M. Crijns, Isabelle C. Van Gelder, Irina Savelieva, A. John Camm · 2002 · Wiley eBooks
  38. Atrial Fibrillation: Rate Versus Rhythm Control
    Carlos Vargas, Mina Bhatnagar, Haris S. Ahmed, Michael G. Flynn, Thomas Alexander · 2023 · HCA Healthcare Journal of Medicine
  39. Dofetilide for the treatment of premature ventricular complexes and ventricular tachycardia in patients with structural heart disease
    Amrish Deshmukh, Miki Yokokawa, Daniel A McBride, Jamie Simpson, Andrew Chou, Michael Ghannam, Jackson Jeikai Liang, Mohammed Saeed, Ryan T. Cunnane, Hamid Ghanbari et al. · 2024 · Journal of Cardiovascular Electrophysiology
  40. Risk Factors Associated with Unsuccessful Dofetilide Initiation Due to Excessive QT Interval Prolongation: A Retrospective Study
    Johnathon J. Rast, Grant C. Whitebloom, Omar Mohamed Makram, Priyanshu Nain, Lakshya Seth, Nathaniel B. Wayne, PATRICK HOULIHAN, Alexander M. Warner, Daniel Sohinki · 2025 · Journal of Innovations in Cardiac Rhythm Management
  41. Treatment of arrhythmias in patients with congestive heart failure
    Robert M. Lobel, Daniel Lawrence Lustgarten · 2004 · Current Treatment Options in Cardiovascular Medicine
  42. Comparison between Carotid Artery Doppler Ultrasound and Coronary Calcium Score as Predictors of Significant Coronary Artery Disease in Patients Undergoing Computed Tomography Coronary Angiography
    Silvia Tresoldi · 2014 · Cardiovascular Pharmacology Open Access
  43. Pharmacologic targets for atrial fibrillation
    Deepak Bhakta, John M. Miller · 2007 · Expert Opinion on Therapeutic Targets
  44. Proarrhythmic Effects of Antiarrhythmic and Non-antiarrhythmic Drugs
    J. William Schleifer, Komandoor S. Srivathsan · 2015 · Springer eBooks
  45. Uso de antiarrítmicos en el tratamiento de la fibrilación auricular. Estrategia de control del ritmo
    Francisco Villegas-García · 2016 · Revista Colombiana de Cardiología
  46. Trends in atrial flutter and atrial tachycardia research
    Edward J. Ciaccio, ANGELO B. BIVIANO, Vivek Iyer, Hasan Garan · 2017 · Informatics in Medicine Unlocked
  47. Pharmacokinetics and Bioequivalence of Branded and Generic Formulations of Dofetilide 0.5‐mg Capsules After Single‐Dose Administration in Healthy Subjects
    James T. VanderLugt, Charles Bon, Dean W. Knuth, Rhonda Schreiber, Michael D. Ruff · 2017 · Clinical Pharmacology in Drug Development
  48. Antiarrhythmic Medications for Cardioversion and Maintenance of Sinus Rhythm in Patients with Cardiac Arrhythmias: A Review of the Literature
    Emily Guhl, Sushil Kumar Jain · 2017 · Cardiovascular Pharmacology Open Access
  49. Whole‐exome sequencing reveals microsatellite DNA markers for response to dofetilide initiation in patients with persistent atrial fibrillation: A pilot study
    Nick Kinney, Timothy R. Larsen, David M. Kim, Robin T. Varghese, Steven Poelzing, Harold R. Garner, Soufian Almahameed · 2018 · Clinical Cardiology
  50. Precision medicine in cardiac electrophysiology: where we are and where we need to go
    Ashish Adrian Correa, Syed Waqas Haider, Wilbert S. Aronow · 2020 · Expert Review of Precision Medicine and Drug Development
  51. Dofetilide dose reductions and discontinuation in obese compared to non-obese patients
    Keith Anderson, Katie M. Greenlee, Maria Matteo, Bruce Larry Wilkoff · 2022 · Journal of Cardiovascular Pharmacology
  52. Atrial Rotor Modulation by Localized Dofetilide Application: An In Silico Study
    Sandra Pérez-Buitrago, Juan Pablo Ugarte, Catalina Tobón · 2018 · Computing in cardiology
  53. Prophylactic Antiarrhythmic Drug Therapy in Atrial Fibrillation.
    Moisés Rodríguez‐Mañero, Andrea Sarkozy, Gian Battista Chierchia, Rubén Casado-Arroyo, Danilo Ricciardi, Carlo de Asmundis, Carlo de A, P Sarkozy · 2013 · Europe PMC (PubMed Central)
  54. Longitudinal QTc stability and impact of baseline cardiac rhythm on discharge dose in dofetilide‐treated patients
    Zeryab A. Khan, Megan E. LaBreck, Jordan M. Luli, Chelsea Roberts, Alexander W. Smith, Rayan S El-Zein, Jaret D Tyler, Eugene Y. Fu, Sreedhar R. Billakanty, Anish K. Amin et al. · 2022 · Journal of Cardiovascular Electrophysiology
  55. Pharmakologische Therapie bei Vorhofflimmern – Was leisten moderne Antiarrhythmika wirklich?
    H Volkmann, L. Richter, Carsten Bergmann · 2008 · Clinical Research in Cardiology Supplements
  56. Atrial Fibrillation: Rhythm and Rate Control Therapies
    Irina Savelieva, Albert L. Waldo, A. John Camm · 2009 · Wiley eBooks
  57. Evolving concepts in the treatment of atrial fibrillation
    Parimal B. Maniar, Jonathan S. Steinberg · 2003 · Current Cardiology Reports
  58. Is it Rational, Reasonable or Excessive, and Consistently Applied? One View of the Increasing FDA Emphasis on Safety First for the Release and Use of Antiarrhythmic Drugs for Supraventricular Arrhythmias
    James A. Reiffel · 2001 · Journal of Cardiovascular Pharmacology and Therapeutics
  59. Which Is the Ideal Drug for Chronic Prophylaxis of Atrial Fibrillation?
    Giuseppe Boriani, Mauro Biffi, Igor Diemberger, Cristian Martignani, CLAUDIA CAMANINI, Cinzia Valzania, Giulia Domenichini, Ivan Corazza, Angelo Branzi · 2004 · Springer eBooks
  60. Narrow complex tachycardia: recognition and management in the emergency room.
    Ray Ib · 2004 · PubMed
  61. TREATMENT OF ATRIAL FIBRILLATION (REVIEW)
    Roman Efimovich Batalov, Sergey Valentinovich Popov, Юрий Владимирович Егай · 2011 · CyberLeninK (CyberLeninka)
  62. Dofetilide and Atrial Fibrillation
    Linda McAlpine Benson, Dennis C. Powless · 2003 · AJN American Journal of Nursing
  63. Atrial Fibrillation Update: Overview and Highlights of New Information
    Albert L. Waldo · 2001 · Cardiac Electrophysiology Review
  64. Acute Termination of Atrial Flutter: Are New Class Antiarrhythmic Drugs the Best Choice?
    N Baldi, Vitantonio Russo, Vincenzo Morrone, Leonardo Di Gregorio, L. Liconso, Giovanni Polimeni · 2002 · Springer eBooks
  65. Understanding the Genetic Basis of Atrial Fibrillation: Towards a Pharmacogenetic Approach for Arrhythmia Treatment
    Jason D. Roberts, Michael H. Gollob · 2013 · Springer eBooks
  66. Results of Clinical Trials on Atrial Fibrillation
    D. George Wyse · 2004 · Elsevier eBooks
  67. Treatment of Cardiac Arrhythmias
    Davendra Mehta · 2007 · Humana Press eBooks
  68. Minimally Invasive Surgical Approach to Treat Atrial Fibrillation
    Mustafa Guden, Belhhan Akpynar, Osman Bayndur · 2008
  69. Nuevos antiarrítmicos en la fibrilación auricular
    Gustavo Pastelín Hernández, Pastor Luna Ortíz, Fermín Alejandro Tenorio López, Leonardo del Valle‐Mondragón · 2007 · Revista Portuguesa de Pneumologia
  70. Pericardioversion Dofetilide Does Not Suppress Immediate and Subacute Recurrences of Persistent Atrial Fibrillation
    Trudeke Van Noord, Isabelle C. Van Gelder, Harry J.G.M. Crijns · 2001 · Circulation
  71. Antiarrhythmic drugs
    Aman Mahajan, Charles W. Jr Hogue · 2011 · Cambridge University Press eBooks
  72. Dofetilide for Atrial Flutter and Fibrillation
    Poul Erik Bloch Thomsen · 2000 · Cardiac Electrophysiology Review
  73. Cardioversión eléctrica y farmacológica de la fibrilación auricular
    Susan S. Kim, Bradley P. Knight · 2008 · Clínicas médicas de Norteamérica
  74. Novel therapies for treating atrial fibrillation
    Raj Parikh, Philip J. Kadowitz · 2012 · World Journal of Cardiovascular Diseases
  75. Review of the current management of atrial fibrillation
    Paul A. Gould, John Power, Archer Broughton, David M. Kaye · 2003 · Expert Opinion on Pharmacotherapy
  76. Manejo de la fibrilación auricular en atención primaria: a propósito de un caso
    Jordi Durán Rabés, Javier Gervilla Caño, Jorge Soler-González · 2006 · FMC - Formación Médica Continuada en Atención Primaria
  77. ALLHAT and AFFIRM
    Philip R. Liebson · 2003 · Preventive Cardiology
  78. The Year in Review: Cardiology
    Cynthia A. Sanoski · 2001 · Journal of Pharmacy Practice
  79. Pharmacologic conversion of atrial fibrillation: a systematic review of available evidence
    Richard S Slavik · 2003 · Current Problems in Cardiology
  80. Treatment of Atrial Fibrillation and Flutter: Focus on Oral Dofetilide, a New Selective Class III Antiarrhythmic Agent
    Pang H Chong, Cory M. Franklin, Barbara T. Yim · 2001 · Heart Drug
  81. ESC COMMITTEE FOR PRACTICE GUIDELINES & POLICY CONFERENCES MEMBERS
    Valentı́n Fuster, L. Samüel Wann, Robert L. McNamara, Eric N. Prystowsky, Raymond J. Gibbons, Elliott Marshall Antman, Joseph S. Alpert, Gabriel Gregoratos · 2001
  82. Evaluation of New Non-Pharmacological Therapies for Symptomatic Atrial Fibrillation With Special Emphasis on the Maze Procedure
    Stefan Lönnerholm · 2002 · KTH Publication Database DiVA (KTH Royal Institute of Technology)
  83. Pharmacologic Management of Atrial Fibrillation and Flutter
    Deepak S. Saluja, Kathleen T. Hickey, James A. Reiffel · 2010 · Humana Press eBooks
  84. Medikamentöse und alternative Konzepte zur Behandlung von Vorhofflimmern: Neuere Klasse-III-Antiarrhythmika, Hybridtherapien (Kardioversion-Defibrillation, Ablation, Pacing)
    Helmut Pürerfellner · 2004 · Journal für Kardiologie (Krause & Pachernegg GmbH)
  85. Sotalol Pretreatment for Electrical Cardioversion of Atrial Fibrillation
    Trudeke Van Noord, Isabelle C. Van Gelder, Harry J.G.M. Crijns · 2003 · Journal of Cardiovascular Electrophysiology
  86. A TRIAL F IBRILLATION
    R Odney H. F Alk · 2001
  87. Preventing Recurrences: Classic and Modern Antiarrhythmic Drugs in Atrial
    FibrillationUrda Víctor, Toquero Ramos Jorge, Ignacio Fernández Lozano · 2015
  88. The role of radiofrequency ablation as a first line therapy in the treatment of atrial flutter.
    Radu Roşu, Lucian Mureşan, Marius Andronache, Dana Pop, C Pop, Maria Pușchiță, Adina Mălai, Gabriel Guşetu, Dumitru Tudor Zdrenghea · 2010 · PubMed
  89. 不整脈：診断と治療の進歩 ＩＩ．治療 ３．不整脈の薬物療法の現状と展望 ３）ＩＩＩ群抗不整脈薬をどう使うか
    Akira Fujiki · 2006 · Nihon Naika Gakkai Zasshi
  90. Better research is needed to develop, subclassify, and identify new therapeutic targets, which hold the promise that precise therapies aimed at preventing or reversing AF will be developed. Antiarrhythmic therapeutic strategies for AF should be focused on controlling pathophysiologic re- modeling, with better prevention and disease-modifying strategies.
    Muhammad Rizwan Sardar, Wajeeha Saeed, Peter Russell Kowey · 2014
  91. Dofetilide: A New Option for Patients with Atrial Fibrillation
    Hugh G Calkins · 2001 · Journal watch
  92. Pharmacologic Management of Atrial Fibrillation
    John K. Finkle, Kenneth Plunkitt, Peter Russell Kowey · 2002 · Contemporary cardiology
  93. Management and ablation of atrial flutter
    Dhanunjaya Lakkireddy, Dimpi Patel, Tamer Salah Eldin Fahmy, PATRICK J. TCHOU, Mauricio S. Arruda · 2007 · CRC Press eBooks
  94. Outpatient Medications in Atrial Fibrillation
    Laura Kristin Newby, Sean D. Pokorney · 2016 · Contemporary cardiology
  95. Acute and Chronic Pharmacologic Management of Supraventricular Tachycardias
    James Michael Mangrum, John Ferguson, John Dimarco · 2007 · Elsevier eBooks
  96. Atrial fibrillation and supraventricular arrhythmias
    Demosthenes G. Katritsis, A. John Camm · 2021 · Oxford University Press eBooks
  97. Glass Half Empty? ∗
    Peter Russell Kowey, Ashish M. Shah · 2016 · JACC. Clinical electrophysiology
  98. Pharmacologic of Atrial Fibrillation and Atrial Flutter
    Alessandro Marinelli, Alessandro Capucci · 2010
  99. Arrhythmias in Cardiomyopathy
    Henri Roukoz, Wayne O. Adkisson, Barış Akdemir, Balaji Krishnan, Scott Sakaguchi, David G. Benditt · 2017 · Springer eBooks
  100. Safety and Efficacy of Dofetilide Therapy in a Veterans Affairs Population: The DT-VAP Study
    Frank Chen · 2017 · Pharmacy & Pharmacology International Journal